TOP 10 Targeted therapy for cancer in Memphis, Tennessee

Boston Baskin Cancer Group is a renowned health institution located at 6027 Walnut Grove Road in Memphis, Tennessee, United States. As a leading cancer hospital, we are dedicated to providing top-notch care and cutting-edge treatments for cancer patients. Our team of skilled healthcare professionals is committed to delivering personalized and compassionate care to help our patients fight against cancer. With state-of-the-art facilities and a multidisciplinary approach to treatment, Boston Baskin Cancer Group is a trusted choice for those seeking high-quality cancer care.

The U T Cancer Institute, located at 3950 New Covington Pike in Memphis, Tennessee, United States, is a leading healthcare institution specializing in the treatment and research of various types of cancer. With a team of dedicated doctors and health professionals, the institute offers cutting-edge treatment options and personalized care for patients battling cancer. From diagnosis to survivorship, the U T Cancer Institute is committed to providing the highest quality of care and support to those affected by cancer.

The Family Cancer Center is a leading healthcare institution located at 6005 Park Avenue in Memphis, Tennessee. Our dedicated team of doctors and health professionals specialize in providing comprehensive care and support to families affected by cancer. From diagnosis to treatment and survivorship, we offer personalized care plans tailored to each patient's unique needs. With state-of-the-art facilities and cutting-edge technology, we are committed to delivering the highest standard of care to our patients. Visit us today to learn more about our services and how we can help you and your loved ones on the journey to healing and recovery.

Dr. Lillian Guenther's institution, located at 262 Danny Thomas Place in Memphis, Tennessee, is dedicated to researching and treating challenging cancers, with a specific focus on osteosarcoma, the most common malignant bone tumor in children. The laboratory at this institution examines the genetic drivers behind osteosarcoma using genome-scale screening techniques and diverse models. Dr. Guenther and her team are investigating new combination approaches to treatment based on their understanding of osteosarcoma's genetic landscape. Their goal is to uncover highly effective therapeutic strategies for children with this aggressive disease. The Guenther Lab Team consists of individuals performing clinical trials work in sarcomas and solid tumors, with a strong focus on understanding the complex genome of osteosarcoma. Dr. Guenther's research uses genome-scale CRISPR screening to examine critical non-mutated genes in the osteosarcoma cancer genome, with a specific focus on the DNA damage response cascade. By investigating promising osteosarcoma dependency genes, including those involved in DNA damage repair, Dr. Guenther aims to find ways to harness cancer cell vulnerabilities that will transform osteosarcoma treatment.

Dr. Victor Santana is a renowned health institution located at 262 Danny Thomas Place in Memphis, Tennessee, United States. Dr. Santana holds a Bachelor of Science from Catholic University of Puerto Rico in Ponce, Puerto Rico, and a Doctor of Medicine from the University of Puerto Rico School of Medicine in San Juan, Puerto Rico. The institution specializes in pediatric oncology and offers cutting-edge treatments for children with high-risk neuroblastoma, osteosarcoma, and other solid tumors. Dr. Santana and his team have conducted numerous research studies and clinical trials to improve treatment outcomes for young patients with cancer.

Kelsey Bertrand is a renowned doctor specializing in pediatric hematology-oncology, located at 262 Danny Thomas Place in Memphis, Tennessee, United States. Dr. Bertrand holds a BS from the University of Guelph in Canada, an MS from the University of Toronto in Canada, and an MD from the University of Queensland in Australia. She completed her residency in Pediatrics at Cleveland Clinic Children's Hospital in Ohio and a fellowship in Pediatric Hematology-Oncology at Baylor College of Medicine in Texas. Dr. Bertrand has contributed significantly to the field of oncology with her research and publications in top medical journals. She has a particular interest in ependymomas and other brain cancers, focusing on identifying pathways of drug resistance and developing targeted therapies. Her work has been recognized for its impact on improving treatment outcomes for patients with these challenging diseases.

OncoMetrix is a leading health institution located at 3495 Hacks Cross Road in Memphis, Tennessee, United States. Specializing in oncology, OncoMetrix offers cutting-edge treatments and personalized care for patients battling cancer. With a team of experienced physicians, researchers, and specialists, OncoMetrix is dedicated to providing the highest quality of care and support for individuals and families affected by cancer. Their state-of-the-art facilities and innovative approach to cancer treatment make them a trusted destination for oncology care in the region.